Diadema Partners Lp Top Holdings and 13F Report (2025)

About Diadema Partners Lp

Investment Activity

Diadema Partners Lp has $383.27 million in total holdings as of March 31, 2025.
Diadema Partners Lp owns shares of 72 different stocks, but just 19 companies or ETFs make up 80% of its holdings.
Approximately 78.69% of the portfolio was purchased this quarter.
About 40.02% of the portfolio was sold this quarter.
This quarter, Diadema Partners Lp has purchased 86 new stocks and bought additional shares in 25 stocks.
Diadema Partners Lp sold shares of 16 stocks and completely divested from 45 stocks this quarter.

Largest Holdings

Amgen: $48,414,870
Eli Lilly and Company: $41,297,152
Soleno Therapeutics: $37,825,773
Regeneron Pharmaceuticals: $31,602,412
Pfizer: $22,806,000

Largest New Holdings this Quarter

031162100 - Amgen: $48,414,870 Holding
532457108 - Eli Lilly and Company: $41,297,152 Holding
75886F107 - Regeneron Pharmaceuticals: $31,602,412 Holding
717081103 - Pfizer: $22,806,000 Holding
218352102 - Corcept Therapeutics: $21,724,644 Holding

Largest Purchases this Quarter

Amgen: 155,400 shares (about $48.41M)
Eli Lilly and Company: 50,002 shares (about $41.30M)
Regeneron Pharmaceuticals: 49,828 shares (about $31.60M)
Pfizer: 900,000 shares (about $22.81M)
Corcept Therapeutics: 190,200 shares (about $21.72M)

Largest Sales this Quarter

CRISPR Therapeutics: 78,800 shares (about $2.68M)
Ascendis Pharma A/S: 16,955 shares (about $2.64M)
Capricor Therapeutics: 228,400 shares (about $2.17M)
AnaptysBio: 100,900 shares (about $1.88M)
TG Therapeutics: 39,922 shares (about $1.57M)

Sector Allocation Over Time

Selling

Neutral

Buying

Latest 13F Holdings and Changes Since Previous Quarterly Filing

Issuer Name	Holdings Value	Approximate Purchase/Sale	Change in Shares	Shares Held	% of Portfolio	Sector
AMGN Amgen	$48,414,870	$48,414,870 ▲	New Holding	155,400	12.6%	Medical
LLY Eli Lilly and Company	$41,297,152	$41,297,152 ▲	New Holding	50,002	10.8%	Medical
SLNO Soleno Therapeutics	$37,825,773	$13,390,730 ▲	54.8%	529,402	9.9%	Medical
REGN Regeneron Pharmaceuticals	$31,602,412	$31,602,412 ▲	New Holding	49,828	8.2%	Medical
PFE Pfizer	$22,806,000	$22,806,000 ▲	New Holding	900,000	6.0%	Medical
CORT Corcept Therapeutics	$21,724,644	$21,724,644 ▲	New Holding	190,200	5.7%	Medical
JAZZ Jazz Pharmaceuticals	$19,626,749	$17,799,385 ▲	974.0%	158,089	5.1%	Medical
NVO Novo Nordisk A/S	$17,876,784	$17,876,784 ▲	New Holding	257,918	4.7%	Medical
ALNY Alnylam Pharmaceuticals	$8,941,712	$8,941,712 ▲	New Holding	33,115	2.3%	Medical
RARE Ultragenyx Pharmaceutical	$8,701,263	$2,987,325 ▲	52.3%	240,300	2.3%	Medical
TGTX TG Therapeutics	$8,196,827	$1,574,125 ▼	-16.1%	207,883	2.1%	Medical
ARGX argenx	$7,179,027	$6,782,044 ▲	1,708.4%	12,279	1.9%	Medical
NBIX Neurocrine Biosciences	$6,884,518	$6,884,518 ▲	New Holding	62,247	1.8%	Medical
APOGEE THERAPEUTICS INC	$6,212,968	$4,321,805 ▲	228.5%	166,300	1.6%	COM
PCVX Vaxcyte	$5,436,874	$5,059,274 ▲	1,339.9%	143,985	1.4%	Medical
BBIO BridgeBio Pharma	$4,542,498	$1,085,498 ▲	31.4%	131,400	1.2%	Medical
MRNA Moderna	$4,312,035	$4,312,035 ▲	New Holding	152,100	1.1%	Medical
ANAB AnaptysBio	$3,980,119	$1,875,731 ▼	-32.0%	214,100	1.0%	Medical
CRSP CRISPR Therapeutics	$3,811,360	$2,681,564 ▼	-41.3%	112,000	1.0%	Medical
BMRN BioMarin Pharmaceutical	$3,737,875	$3,737,875 ▲	New Holding	52,877	1.0%	Medical
VKTX Viking Therapeutics	$3,722,022	$3,722,022 ▲	New Holding	154,121	1.0%	Medical
RXRX Recursion Pharmaceuticals	$3,694,536	$2,107,536 ▲	132.8%	698,400	1.0%	Medical
COGT Cogent Biosciences	$3,555,742	$3,016,642 ▲	559.6%	593,613	0.9%	Medical
AGIO Agios Pharmaceuticals	$3,507,210	$518,610 ▲	17.4%	119,700	0.9%	Medical
IMCR Immunocore	$2,877,515	$2,877,515 ▲	New Holding	96,984	0.8%	Medical
KALV KalVista Pharmaceuticals	$2,755,856	$2,755,856 ▲	New Holding	238,809	0.7%	Medical
RYTM Rhythm Pharmaceuticals	$2,648,500	$1,324,250 ▼	-33.3%	50,000	0.7%	Medical
SWTX SpringWorks Therapeutics	$2,647,800	$2,647,800 ▲	New Holding	60,000	0.7%	Medical
MNKD MannKind	$2,615,097	$2,615,097 ▲	New Holding	519,900	0.7%	Medical
CNTA Centessa Pharmaceuticals	$2,359,010	$462,835 ▲	24.4%	164,048	0.6%	Medical
VRDN Viridian Therapeutics	$2,184,609	$1,517,646 ▲	227.5%	162,063	0.6%	Medical
KROS Keros Therapeutics	$2,169,451	$316,369 ▼	-12.7%	212,900	0.6%	Medical
EWTX Edgewise Therapeutics	$2,160,400	$2,130,502 ▲	7,125.9%	98,200	0.6%	Medical
ZYME Zymeworks	$2,135,463	$2,135,463 ▲	New Holding	179,300	0.6%	Medical
ALT Altimmune	$2,094,000	$1,094,000 ▲	109.4%	418,800	0.5%	Medical
QURE uniQure	$2,020,360	$960,360 ▲	90.6%	190,600	0.5%	Medical
SRRK Scholar Rock	$1,862,224	$1,229,319 ▼	-39.8%	57,923	0.5%	Medical
ETNB 89bio	$1,682,540	$1,682,540 ▲	New Holding	231,436	0.4%	Medical
RLAY Relay Therapeutics	$1,461,295	$125,844 ▼	-7.9%	557,746	0.4%	Medical
SAGE Sage Therapeutics	$1,458,555	$1,458,555 ▲	New Holding	183,466	0.4%	Medical
MREO Mereo BioPharma Group	$1,416,362	$1,416,362 ▲	New Holding	1,046,815	0.4%	Medical
VTGN Vistagen Therapeutics	$1,415,438	$308,638 ▲	27.9%	566,175	0.4%	Medical
ASND Ascendis Pharma A/S	$1,296,911	$2,642,606 ▼	-67.1%	8,321	0.3%	Medical
GOSS Gossamer Bio	$1,203,828	$681,452 ▲	130.5%	1,094,389	0.3%	Medical
TRVI Trevi Therapeutics	$1,132,200	$1,132,200 ▲	New Holding	180,000	0.3%	Medical
FOLD Amicus Therapeutics	$1,072,224	$256,224 ▲	31.4%	131,400	0.3%	Medical
OCUL Ocular Therapeutix	$1,002,011	$239,691 ▲	31.4%	136,700	0.3%	Medical
PCRX Pacira BioSciences	$967,311	$967,311 ▲	New Holding	38,926	0.3%	Medical
URGN UroGen Pharma	$842,993	$289,993 ▲	52.4%	76,220	0.2%	Medical
ELYM Eliem Therapeutics	$817,160	$360,364 ▲	78.9%	669,803	0.2%	Medical
CYTK Cytokinetics	$803,800	$803,800 ▲	New Holding	20,000	0.2%	Medical
REPL Replimune Group	$726,668	$384,833 ▼	-34.6%	74,530	0.2%	Medical
CRDF Cardiff Oncology	$653,434	$653,434 ▲	New Holding	208,100	0.2%	Medical
RVPH Reviva Pharmaceuticals	$620,660	$620,660 ▲	New Holding	650,723	0.2%	Medical
EOLS Evolus	$601,500	$570,499 ▼	-48.7%	50,000	0.2%	Medical
UBX Unity Biotechnology	$584,584	$584,584 ▲	New Holding	562,100	0.2%	Medical
ALEC Alector	$561,552	$267,558 ▲	91.0%	456,546	0.1%	Medical
VERV Verve Therapeutics	$534,233	$534,233 ▲	New Holding	116,900	0.1%	Medical
SMMT Summit Therapeutics	$476,463	$73,302 ▼	-13.3%	24,700	0.1%	Medical
SAVA Cassava Sciences	$464,850	$92,100 ▼	-16.5%	309,900	0.1%	Medical
NKTR Nektar Therapeutics	$461,176	$14,089 ▼	-3.0%	678,200	0.1%	Medical
CMPX Compass Therapeutics	$380,000	$380,000 ▲	New Holding	200,000	0.1%	Medical
OLMA Olema Pharmaceuticals	$376,000	$376,000 ▲	New Holding	100,000	0.1%	Medical
BMEA Biomea Fusion	$362,313	$210,231 ▲	138.2%	170,100	0.1%	Medical
IMUX Immunic	$346,402	$346,402 ▲	New Holding	317,800	0.1%	Medical
CAPR Capricor Therapeutics	$287,547	$2,167,516 ▼	-88.3%	30,300	0.1%	Medical
PRQR ProQR Therapeutics	$276,233	$66,062 ▲	31.4%	207,694	0.1%	Medical
ELDN Eledon Pharmaceuticals	$219,038	$37,904 ▼	-14.8%	64,613	0.1%	Medical
LIFE aTyr Pharma	$200,830	$200,830 ▲	New Holding	66,500	0.1%	Medical
TERN Terns Pharmaceuticals	$154,830	$15,809 ▲	11.4%	56,098	0.0%	Medical
SAGIMET BIOSCIENCES INC	$150,022	$150,022 ▲	New Holding	46,019	0.0%	COM SER A
CADL Candel Therapeutics	$141,504	$157,380 ▼	-52.7%	25,045	0.0%	Medical
VRTX Vertex Pharmaceuticals	$0	$23,114,980 ▼	-100.0%	0	0.0%	Medical
XBI SPDR S&P Biotech ETF	$0	$18,012,000 ▼	-100.0%	0	0.0%	ETF
ABBV AbbVie	$0	$17,770,000 ▼	-100.0%	0	0.0%	Medical
BMY Bristol-Myers Squibb	$0	$9,049,600 ▼	-100.0%	0	0.0%	Medical
ACLX Arcellx	$0	$8,443,569 ▼	-100.0%	0	0.0%	Medical
INSM Insmed	$0	$7,341,506 ▼	-100.0%	0	0.0%	Medical
TEVA Teva Pharmaceutical Industries	$0	$6,676,648 ▼	-100.0%	0	0.0%	Medical
BPMC Blueprint Medicines	$0	$5,598,913 ▼	-100.0%	0	0.0%	Medical
HALO Halozyme Therapeutics	$0	$4,781,000 ▼	-100.0%	0	0.0%	Medical
AZN AstraZeneca	$0	$3,931,781 ▼	-100.0%	0	0.0%	Medical
BHVN Biohaven	$0	$3,735,000 ▼	-100.0%	0	0.0%	Medical
ITCI Intra-Cellular Therapies	$0	$3,649,824 ▼	-100.0%	0	0.0%	Medical
TARS Tarsus Pharmaceuticals	$0	$3,322,200 ▼	-100.0%	0	0.0%	Medical
APLS Apellis Pharmaceuticals	$0	$3,191,000 ▼	-100.0%	0	0.0%	Medical
CLDX Celldex Therapeutics	$0	$2,527,000 ▼	-100.0%	0	0.0%	Medical
RCUS Arcus Biosciences	$0	$2,471,219 ▼	-100.0%	0	0.0%	Medical
ORIC ORIC Pharmaceuticals	$0	$1,729,328 ▼	-100.0%	0	0.0%	Medical
CRNX Crinetics Pharmaceuticals	$0	$1,324,267 ▼	-100.0%	0	0.0%	Medical
DNLI Denali Therapeutics	$0	$1,222,800 ▼	-100.0%	0	0.0%	Medical
NUVL Nuvalent	$0	$1,150,794 ▼	-100.0%	0	0.0%	Medical
BNTX BioNTech	$0	$999,000 ▼	-100.0%	0	0.0%	Medical
JANX Janux Therapeutics	$0	$936,950 ▼	-100.0%	0	0.0%	Medical
NEUMORA THERAPEUTICS INC.	$0	$860,720 ▼	-100.0%	0	0.0%	COM
IOVA Iovance Biotherapeutics	$0	$740,000 ▼	-100.0%	0	0.0%	Medical
VIR Vir Biotechnology	$0	$734,000 ▼	-100.0%	0	0.0%	Medical
GHRS GH Research	$0	$710,514 ▼	-100.0%	0	0.0%	Medical
GERN Geron	$0	$708,000 ▼	-100.0%	0	0.0%	Medical
AVTE Aerovate Therapeutics	$0	$507,740 ▼	-100.0%	0	0.0%	Medical

Showing largest 100 holdings. View all holdings.

More Institutional Buying and Selling Information

SEC Filings and Trading Data

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Diadema Partners Lp Top Holdings and 13F Report (2025)

About Diadema Partners Lp

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Diadema Partners Lp Top Holdings and 13F Report (2025)

About Diadema Partners Lp

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Map of 500 Largest Holdings ofDiadema Partners Lp

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools